ID   NOTC1_RAT               Reviewed;        2531 AA.
AC   Q07008; F1M9E7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   16-OCT-2013, sequence version 3.
DT   02-OCT-2024, entry version 227.
DE   RecName: Full=Neurogenic locus notch homolog protein 1;
DE            Short=Notch 1;
DE   Contains:
DE     RecName: Full=Notch 1 extracellular truncation;
DE              Short=NEXT;
DE   Contains:
DE     RecName: Full=Notch 1 intracellular domain;
DE              Short=NICD;
DE   Flags: Precursor;
GN   Name=Notch1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Schwann cell;
RX   PubMed=1764995; DOI=10.1242/dev.113.1.199;
RA   Weinmaster G., Roberts V.J., Lemke G.;
RT   "A homolog of Drosophila Notch expressed during mammalian development.";
RL   Development 113:199-205(1991).
RN   [2]
RP   SEQUENCE REVISION TO 1652-1653.
RA   Weinmaster G.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION.
RX   PubMed=11182080; DOI=10.1016/s0896-6273(01)00179-9;
RA   Tanigaki K., Nogaki F., Takahashi J., Tashiro K., Kurooka H., Honjo T.;
RT   "Notch1 and Notch3 instructively restrict bFGF-responsive multipotent
RT   neural progenitor cells to an astroglial fate.";
RL   Neuron 29:45-55(2001).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=1295745; DOI=10.1242/dev.116.4.931;
RA   Weinmaster G., Roberts V.J., Lemke G.;
RT   "Notch2: a second mammalian Notch gene.";
RL   Development 116:931-941(1992).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=11438922; DOI=10.1002/cne.1059.abs;
RA   Irvin D.K., Zurcher S.D., Nguyen T., Weinmaster G., Kornblum H.I.;
RT   "Expression patterns of Notch1, Notch2, and Notch3 suggest multiple
RT   functional roles for the Notch-DSL signaling system during brain
RT   development.";
RL   J. Comp. Neurol. 436:167-181(2001).
RN   [8] {ECO:0007744|PDB:4XL1, ECO:0007744|PDB:4XLW}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 412-526 IN COMPLEX WITH DLL4 AND
RP   CALCIUM, GLYCOSYLATION AT SER-435; SER-458; THR-466 AND SER-496, AND
RP   DISULFIDE BONDS.
RX   PubMed=25700513; DOI=10.1126/science.1261093;
RA   Luca V.C., Jude K.M., Pierce N.W., Nachury M.V., Fischer S., Garcia K.C.;
RT   "Structural biology. Structural basis for Notch1 engagement of Delta-like
RT   4.";
RL   Science 347:847-853(2015).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands Jagged-1
CC       (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate
CC       determination (By similarity). Upon ligand activation through the
CC       released notch intracellular domain (NICD) it forms a transcriptional
CC       activator complex with RBPJ/RBPSUH and activates genes of the enhancer
CC       of split locus (By similarity). Affects the implementation of
CC       differentiation, proliferation and apoptotic programs (By similarity).
CC       Involved in angiogenesis; negatively regulates endothelial cell
CC       proliferation and migration and angiogenic sprouting (By similarity).
CC       Involved in the maturation of both CD4(+) and CD8(+) cells in the
CC       thymus (By similarity). Important for follicular differentiation and
CC       possibly cell fate selection within the follicle (By similarity).
CC       During cerebellar development, functions as a receptor for neuronal
CC       DNER and is involved in the differentiation of Bergmann glia
CC       (PubMed:11182080). Represses neuronal and myogenic differentiation (By
CC       similarity). May play an essential role in postimplantation
CC       development, probably in some aspect of cell specification and/or
CC       differentiation (By similarity). May be involved in mesoderm
CC       development, somite formation and neurogenesis (By similarity). May
CC       enhance HIF1A function by sequestering HIF1AN away from HIF1A (By
CC       similarity). Required for the THBS4 function in regulating protective
CC       astrogenesis from the subventricular zone (SVZ) niche after injury (By
CC       similarity). Involved in determination of left/right symmetry by
CC       modulating the balance between motile and immotile (sensory) cilia at
CC       the left-right organiser (LRO) (By similarity).
CC       {ECO:0000250|UniProtKB:Q01705, ECO:0000269|PubMed:11182080}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and an N-terminal
CC       fragment N(EC) which are probably linked by disulfide bonds. Interacts
CC       with DNER, DTX1, DTX2 and RBPJ/RBPSUH. Also interacts with MAML1, MAML2
CC       and MAML3 which act as transcriptional coactivators for NOTCH1. Notch 1
CC       intracellular domain interacts with SNW1; the interaction involves
CC       multimerized NOTCH1 NICD and is implicated in a formation of an
CC       intermediate preactivation complex which associates with DNA-bound CBF-
CC       1/RBPJ. The activated membrane-bound form interacts with AAK1 which
CC       promotes NOTCH1 stabilization. Forms a trimeric complex with FBXW7 and
CC       SGK1. Interacts with HIF1AN. HIF1AN negatively regulates the function
CC       of notch intracellular domain (NICD), accelerating myogenic
CC       differentiation. Interacts (via NICD) with SNAI1 (via zinc fingers);
CC       the interaction induces SNAI1 degradation via MDM2-mediated
CC       ubiquitination and inhibits SNAI1-induced cell invasion. Interacts (via
CC       NICD) with MDM2A. Interacts (via NICD) with BCL6; the interaction
CC       decreases MAML1 recruitment by NOTCH1 NICD on target genes DNA and
CC       inhibits NOTCH1 transcractivation activity (By similarity). Interacts
CC       with THBS4 (By similarity). Interacts (via the EGF-like repeat region)
CC       with CCN3 (via CTCK domain) (By similarity). Interacts (via EGF-like
CC       domains) with DLL4 (via N-terminal DSL and MNNL domains)
CC       (PubMed:25700513). Interacts with ZMIZ1 (By similarity). Interacts (via
CC       NICD domain) with MEGF10 (via the cytoplasmic domain). Interacts with
CC       DLL1 and JAG1 (By similarity). Interacts (via NICD domain) with PRAG1
CC       (By similarity). Forms a complex with PRAG1, N1ICD and MAML1, in a
CC       MAML1-dependent manner (By similarity). Interacts (via transmembrane
CC       region) with PSEN1; the interaction is direct (By similarity).
CC       Interacts with ZFP64 (By similarity). {ECO:0000250|UniProtKB:P46531,
CC       ECO:0000250|UniProtKB:Q01705, ECO:0000269|PubMed:25700513}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q01705};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q01705}.
CC   -!- SUBCELLULAR LOCATION: [Notch 1 intracellular domain]: Nucleus
CC       {ECO:0000250|UniProtKB:Q01705}. Note=Following proteolytical processing
CC       NICD is translocated to the nucleus. Nuclear location may require
CC       MEGF10. {ECO:0000250|UniProtKB:Q01705}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, kidney and spleen.
CC       Expressed in postnatal central nervous system (CNS) germinal zones and,
CC       in early postnatal life, within numerous cells throughout the CNS.
CC       Found in both subventricular and ventricular germinal zones.
CC       {ECO:0000269|PubMed:11438922, ECO:0000269|PubMed:1295745}.
CC   -!- DEVELOPMENTAL STAGE: In the embryo, highest levels occur between days
CC       12 and 14 and decrease rapidly to much lower levels in the adult.
CC   -!- DOMAIN: Interaction with PSEN1 causes partial unwinding of the
CC       transmembrane helix, facilitating access to the scissile peptide bond.
CC       {ECO:0000250|UniProtKB:P46531}.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form which
CC       is proteolytically cleaved by a furin-like convertase in the trans-
CC       Golgi network before it reaches the plasma membrane to yield an active,
CC       ligand-accessible form. Cleavage results in a C-terminal fragment N(TM)
CC       and a N-terminal fragment N(EC). Following ligand binding, it is
CC       cleaved by ADAM17 to yield a membrane-associated intermediate fragment
CC       called notch extracellular truncation (NEXT). Following endocytosis,
CC       this fragment is then cleaved by one of the catalytic subunits of
CC       gamma-secretase (PSEN1 or PSEN2) to release a Notch-derived peptide
CC       containing the intracellular domain (NICD) from the membrane.
CC       {ECO:0000250|UniProtKB:Q01705}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- PTM: O-glycosylated on the EGF-like domains. O-glucosylated at Ser-435
CC       by KDELC1 and KDELC2 (By similarity). Contains both O-linked fucose and
CC       O-linked glucose in the EGF-like domains 11, 12 and 13, which are
CC       interacting with the residues on DLL4 (PubMed:25700513). O-linked
CC       glycosylation by GALNT11 is involved in determination of left/right
CC       symmetry: glycosylation promotes activation of NOTCH1, possibly by
CC       promoting cleavage by ADAM17, modulating the balance between motile and
CC       immotile (sensory) cilia at the left-right organiser (LRO). MFNG-,
CC       RFNG- and LFNG-mediated modification of O-fucose residues at specific
CC       EGF-like domains results in inhibition of its activation by JAG1 and
CC       enhancement of its activation by DLL1 via an increased binding to DLL1
CC       (By similarity). {ECO:0000250|UniProtKB:P46531,
CC       ECO:0000250|UniProtKB:Q01705, ECO:0000269|PubMed:25700513}.
CC   -!- PTM: Ubiquitinated. Undergoes 'Lys-29'-linked polyubiquitination by
CC       ITCH; promotes the lysosomal degradation of non-activated internalized
CC       NOTCH1. Monoubiquitination at Lys-1749 is required for activation by
CC       gamma-secretase cleavage, it promotes interaction with AAK1, which
CC       stabilizes it. Deubiquitination by EIF3F is necessary for nuclear
CC       import of activated Notch. {ECO:0000250|UniProtKB:Q01705}.
CC   -!- PTM: Hydroxylated at Asn-1945 and Asn-2012 by HIF1AN. Hydroxylation
CC       reduces affinity for HI1AN and may thus indirectly modulate negative
CC       regulation of NICD (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57405; CAA40667.1; -; mRNA.
DR   EMBL; AABR06021907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06021908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474001; EDL93491.1; -; Genomic_DNA.
DR   PIR; S18188; S18188.
DR   RefSeq; NP_001099191.1; NM_001105721.1.
DR   PDB; 4XL1; X-ray; 2.30 A; A/D=412-526.
DR   PDB; 4XLW; X-ray; 3.39 A; A/C/E/G=412-526.
DR   PDB; 5UK5; X-ray; 2.51 A; A=295-488.
DR   PDBsum; 4XL1; -.
DR   PDBsum; 4XLW; -.
DR   PDBsum; 5UK5; -.
DR   AlphaFoldDB; Q07008; -.
DR   SMR; Q07008; -.
DR   BioGRID; 247529; 1.
DR   IntAct; Q07008; 3.
DR   STRING; 10116.ENSRNOP00000026212; -.
DR   GlyCosmos; Q07008; 47 sites, No reported glycans.
DR   GlyGen; Q07008; 48 sites.
DR   iPTMnet; Q07008; -.
DR   PhosphoSitePlus; Q07008; -.
DR   PaxDb; 10116-ENSRNOP00000026212; -.
DR   Ensembl; ENSRNOT00000026212.8; ENSRNOP00000026212.6; ENSRNOG00000019322.8.
DR   GeneID; 25496; -.
DR   KEGG; rno:25496; -.
DR   UCSC; RGD:3187; rat.
DR   AGR; RGD:3187; -.
DR   CTD; 4851; -.
DR   RGD; 3187; Notch1.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000157157; -.
DR   HOGENOM; CLU_000576_0_0_1; -.
DR   InParanoid; Q07008; -.
DR   OMA; TCHEQRD; -.
DR   OrthoDB; 5473534at2759; -.
DR   TreeFam; TF351641; -.
DR   EvolutionaryTrace; Q07008; -.
DR   PRO; PR:Q07008; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Proteomes; UP000234681; Chromosome 3.
DR   Bgee; ENSRNOG00000019322; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:RGD.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0002193; C:MAML1-RBP-Jkappa- ICN1 complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005112; F:Notch binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0140537; F:transcription regulator activator activity; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:WormBase.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:1902263; P:apoptotic process involved in embryonic digit morphogenesis; ISO:RGD.
DR   GO; GO:0060842; P:arterial endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0048708; P:astrocyte differentiation; IDA:RGD.
DR   GO; GO:0003162; P:atrioventricular node development; ISO:RGD.
DR   GO; GO:0003181; P:atrioventricular valve morphogenesis; ISO:RGD.
DR   GO; GO:0009912; P:auditory receptor cell fate commitment; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISO:RGD.
DR   GO; GO:0017156; P:calcium-ion regulated exocytosis; ISO:RGD.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; ISO:RGD.
DR   GO; GO:0003207; P:cardiac chamber formation; ISO:RGD.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0003214; P:cardiac left ventricle morphogenesis; ISO:RGD.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; ISO:RGD.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0003213; P:cardiac right atrium morphogenesis; ISO:RGD.
DR   GO; GO:0003219; P:cardiac right ventricle formation; ISO:RGD.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; ISO:RGD.
DR   GO; GO:0060948; P:cardiac vascular smooth muscle cell development; ISO:RGD.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0021515; P:cell differentiation in spinal cord; IEP:RGD.
DR   GO; GO:0003273; P:cell migration involved in endocardial cushion formation; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0071228; P:cellular response to tumor cell; ISO:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0072044; P:collecting duct development; ISO:RGD.
DR   GO; GO:0007386; P:compartment pattern specification; ISO:RGD.
DR   GO; GO:0060982; P:coronary artery morphogenesis; ISO:RGD.
DR   GO; GO:0003182; P:coronary sinus valve morphogenesis; ISO:RGD.
DR   GO; GO:0003169; P:coronary vein morphogenesis; ISO:RGD.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISO:RGD.
DR   GO; GO:0072017; P:distal tubule development; ISO:RGD.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; ISO:RGD.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISO:RGD.
DR   GO; GO:0060956; P:endocardial cell differentiation; ISO:RGD.
DR   GO; GO:0003197; P:endocardial cushion development; ISO:RGD.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISO:RGD.
DR   GO; GO:0003157; P:endocardium development; ISO:RGD.
DR   GO; GO:0003160; P:endocardium morphogenesis; ISO:RGD.
DR   GO; GO:0007492; P:endoderm development; ISO:RGD.
DR   GO; GO:0009957; P:epidermal cell fate specification; ISO:RGD.
DR   GO; GO:0008544; P:epidermis development; ISO:RGD.
DR   GO; GO:0072148; P:epithelial cell fate commitment; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0007440; P:foregut morphogenesis; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0010001; P:glial cell differentiation; ISO:RGD.
DR   GO; GO:0072144; P:glomerular mesangial cell development; ISO:RGD.
DR   GO; GO:0003241; P:growth involved in heart morphogenesis; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0001947; P:heart looping; ISO:RGD.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0006959; P:humoral immune response; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; ISO:RGD.
DR   GO; GO:0002085; P:inhibition of neuroepithelial cell differentiation; ISO:RGD.
DR   GO; GO:0097400; P:interleukin-17-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0070986; P:left/right axis specification; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0001554; P:luteolysis; IEP:RGD.
DR   GO; GO:0014031; P:mesenchymal cell development; ISO:RGD.
DR   GO; GO:0003192; P:mitral valve formation; ISO:RGD.
DR   GO; GO:2000811; P:negative regulation of anoikis; ISO:RGD.
DR   GO; GO:0070168; P:negative regulation of biomineral tissue development; ISO:RGD.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; ISO:RGD.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0060354; P:negative regulation of cell adhesion molecule production; ISO:RGD.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0003252; P:negative regulation of cell proliferation involved in heart valve morphogenesis; ISO:RGD.
DR   GO; GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; ISO:RGD.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2001027; P:negative regulation of endothelial cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0003332; P:negative regulation of extracellular matrix constituent secretion; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045608; P:negative regulation of inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISO:RGD.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; ISO:RGD.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0030279; P:negative regulation of ossification; ISO:RGD.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0046533; P:negative regulation of photoreceptor cell differentiation; ISO:RGD.
DR   GO; GO:2000974; P:negative regulation of pro-B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; ISO:RGD.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0021915; P:neural tube development; ISO:RGD.
DR   GO; GO:0061101; P:neuroendocrine cell differentiation; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISO:RGD.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:WormBase.
DR   GO; GO:0003270; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0003344; P:pericardium morphogenesis; ISO:RGD.
DR   GO; GO:1903849; P:positive regulation of aorta morphogenesis; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1902339; P:positive regulation of apoptotic process involved in morphogenesis; ISO:RGD.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0062043; P:positive regulation of cardiac epithelial to mesenchymal transition; IGI:BHF-UCL.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045603; P:positive regulation of endothelial cell differentiation; IMP:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0045687; P:positive regulation of glial cell differentiation; IMP:RGD.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IMP:RGD.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISO:RGD.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0051152; P:positive regulation of smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; IMP:RGD.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; ISO:RGD.
DR   GO; GO:0050434; P:positive regulation of viral transcription; ISO:RGD.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
DR   GO; GO:0030163; P:protein catabolic process; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISO:RGD.
DR   GO; GO:0003264; P:regulation of cardioblast proliferation; IMP:RGD.
DR   GO; GO:0061344; P:regulation of cell adhesion involved in heart morphogenesis; ISO:RGD.
DR   GO; GO:0030334; P:regulation of cell migration; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0060768; P:regulation of epithelial cell proliferation involved in prostate gland development; ISO:RGD.
DR   GO; GO:1901201; P:regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0045607; P:regulation of inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0050767; P:regulation of neurogenesis; ISO:RGD.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISO:RGD.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISO:RGD.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0032495; P:response to muramyl dipeptide; ISO:RGD.
DR   GO; GO:0042670; P:retinal cone cell differentiation; ISO:RGD.
DR   GO; GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; ISO:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0048103; P:somatic stem cell division; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IMP:RGD.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0072538; P:T-helper 17 type immune response; ISO:RGD.
DR   GO; GO:0042246; P:tissue regeneration; IEP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0035148; P:tube formation; ISS:UniProtKB.
DR   GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; ISO:RGD.
DR   GO; GO:0048845; P:venous blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0060843; P:venous endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISO:RGD.
DR   CDD; cd00054; EGF_CA; 30.
DR   CDD; cd21702; JMTM_Notch1; 1.
DR   Gene3D; 3.30.300.320; -; 1.
DR   Gene3D; 3.30.70.3310; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   Gene3D; 2.10.25.10; Laminin; 35.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   InterPro; IPR022362; Notch_1.
DR   InterPro; IPR024600; Notch_C.
DR   InterPro; IPR051022; Notch_Cell-Fate_Det.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   PANTHER; PTHR24049; CRUMBS FAMILY MEMBER; 1.
DR   PANTHER; PTHR24049:SF30; DELTA-LIKE PROTEIN; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00008; EGF; 18.
DR   Pfam; PF07645; EGF_CA; 4.
DR   Pfam; PF12661; hEGF; 8.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01983; NOTCH.
DR   PRINTS; PR01984; NOTCH1.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 36.
DR   SMART; SM00179; EGF_CA; 32.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 18.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 5.
DR   SUPFAM; SSF90193; Notch domain; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
DR   PROSITE; PS00010; ASX_HYDROXYL; 22.
DR   PROSITE; PS00022; EGF_1; 35.
DR   PROSITE; PS01186; EGF_2; 27.
DR   PROSITE; PS50026; EGF_3; 36.
DR   PROSITE; PS01187; EGF_CA; 21.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Angiogenesis; ANK repeat; Calcium; Cell membrane;
KW   Developmental protein; Differentiation; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Hydroxylation; Isopeptide bond; Membrane; Metal-binding;
KW   Notch signaling pathway; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..2531
FT                   /note="Neurogenic locus notch homolog protein 1"
FT                   /id="PRO_0000007680"
FT   CHAIN           1711..2531
FT                   /note="Notch 1 extracellular truncation"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000007681"
FT   CHAIN           1744..2531
FT                   /note="Notch 1 intracellular domain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000007682"
FT   TOPO_DOM        19..1725
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1726..1746
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P46531"
FT   TOPO_DOM        1747..2531
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          20..58
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          59..99
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          102..139
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          140..176
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          178..216
FT                   /note="EGF-like 5; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          218..255
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          257..293
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          295..333
FT                   /note="EGF-like 8; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          335..371
FT                   /note="EGF-like 9; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          372..410
FT                   /note="EGF-like 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          412..450
FT                   /note="EGF-like 11; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          452..488
FT                   /note="EGF-like 12; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          490..526
FT                   /note="EGF-like 13; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          528..564
FT                   /note="EGF-like 14; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          566..601
FT                   /note="EGF-like 15; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          603..639
FT                   /note="EGF-like 16; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          641..676
FT                   /note="EGF-like 17; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          678..714
FT                   /note="EGF-like 18; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          716..751
FT                   /note="EGF-like 19; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          753..789
FT                   /note="EGF-like 20; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          791..827
FT                   /note="EGF-like 21; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          829..867
FT                   /note="EGF-like 22"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          869..905
FT                   /note="EGF-like 23; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          907..943
FT                   /note="EGF-like 24"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          945..981
FT                   /note="EGF-like 25; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          983..1019
FT                   /note="EGF-like 26"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1021..1057
FT                   /note="EGF-like 27; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1059..1095
FT                   /note="EGF-like 28"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1097..1143
FT                   /note="EGF-like 29"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1145..1181
FT                   /note="EGF-like 30; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1183..1219
FT                   /note="EGF-like 31; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1221..1265
FT                   /note="EGF-like 32; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1267..1305
FT                   /note="EGF-like 33"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1307..1346
FT                   /note="EGF-like 34"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1348..1384
FT                   /note="EGF-like 35"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1387..1426
FT                   /note="EGF-like 36"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          1449..1489
FT                   /note="LNR 1"
FT   REPEAT          1490..1531
FT                   /note="LNR 2"
FT   REPEAT          1532..1571
FT                   /note="LNR 3"
FT   REPEAT          1917..1946
FT                   /note="ANK 1"
FT   REPEAT          1950..1980
FT                   /note="ANK 2"
FT   REPEAT          1984..2013
FT                   /note="ANK 3"
FT   REPEAT          2017..2046
FT                   /note="ANK 4"
FT   REPEAT          2050..2079
FT                   /note="ANK 5"
FT   REGION          420..421
FT                   /note="Interaction with DLL4"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   REGION          448..452
FT                   /note="Interaction with DLL4"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   REGION          1718..1750
FT                   /note="Interaction with PSEN1"
FT                   /evidence="ECO:0000250|UniProtKB:P46531"
FT   REGION          1770..1798
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1937..1945
FT                   /note="HIF1AN-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          2004..2012
FT                   /note="HIF1AN-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          2141..2185
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2382..2428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2440..2531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2160..2177
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2382..2404
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2440..2482
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2490..2524
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         432
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         435
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         452
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         453
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         455
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         469
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         470
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         490
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         491
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         493
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         507
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         508
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   BINDING         1457
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         1460
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         1475
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         1478
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   SITE            469
FT                   /note="Interaction with DLL4"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   SITE            1654..1655
FT                   /note="Cleavage; by furin-like protease"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   SITE            1710..1711
FT                   /note="Cleavage; by ADAM17"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   MOD_RES         1851
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   MOD_RES         1945
FT                   /note="(3S)-3-hydroxyasparagine; by HIF1AN"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2012
FT                   /note="(3S)-3-hydroxyasparagine; by HIF1AN"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        65
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        73
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        116
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        146
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        194
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        232
FT                   /note="O-linked (Fuc...) threonine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        232
FT                   /note="O-linked (GalNAc...) threonine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        311
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        341
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        349
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        378
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        435
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   CARBOHYD        458
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000269|PubMed:25700513"
FT   CARBOHYD        466
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   CARBOHYD        496
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000269|PubMed:25700513"
FT   CARBOHYD        534
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        609
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        617
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        647
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        692
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        722
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        759
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        767
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        784
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        797
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        805
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        888
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        900
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        921
FT                   /note="O-linked (Fuc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        951
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        959
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        997
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1027
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1035
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1065
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1159
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1189
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1197
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1273
FT                   /note="O-linked (Glc...) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1362
FT                   /note="O-linked (Fuc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1379
FT                   /note="O-linked (GlcNAc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1402
FT                   /note="O-linked (Fuc...) threonine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1402
FT                   /note="O-linked (GalNAc...) threonine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CARBOHYD        1489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1587
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1715
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:P46531"
FT   DISULFID        24..37
FT                   /evidence="ECO:0000250"
FT   DISULFID        31..46
FT                   /evidence="ECO:0000250"
FT   DISULFID        48..57
FT                   /evidence="ECO:0000250"
FT   DISULFID        63..74
FT                   /evidence="ECO:0000250"
FT   DISULFID        68..87
FT                   /evidence="ECO:0000250"
FT   DISULFID        89..98
FT                   /evidence="ECO:0000250"
FT   DISULFID        106..117
FT                   /evidence="ECO:0000250"
FT   DISULFID        111..127
FT                   /evidence="ECO:0000250"
FT   DISULFID        129..138
FT                   /evidence="ECO:0000250"
FT   DISULFID        144..155
FT                   /evidence="ECO:0000250"
FT   DISULFID        149..164
FT                   /evidence="ECO:0000250"
FT   DISULFID        166..175
FT                   /evidence="ECO:0000250"
FT   DISULFID        182..195
FT                   /evidence="ECO:0000250"
FT   DISULFID        189..204
FT                   /evidence="ECO:0000250"
FT   DISULFID        206..215
FT                   /evidence="ECO:0000250"
FT   DISULFID        222..233
FT                   /evidence="ECO:0000250"
FT   DISULFID        227..243
FT                   /evidence="ECO:0000250"
FT   DISULFID        245..254
FT                   /evidence="ECO:0000250"
FT   DISULFID        261..272
FT                   /evidence="ECO:0000250"
FT   DISULFID        266..281
FT                   /evidence="ECO:0000250"
FT   DISULFID        283..292
FT                   /evidence="ECO:0000250"
FT   DISULFID        299..312
FT                   /evidence="ECO:0000250"
FT   DISULFID        306..321
FT                   /evidence="ECO:0000250"
FT   DISULFID        323..332
FT                   /evidence="ECO:0000250"
FT   DISULFID        339..350
FT                   /evidence="ECO:0000250"
FT   DISULFID        344..359
FT                   /evidence="ECO:0000250"
FT   DISULFID        361..370
FT                   /evidence="ECO:0000250"
FT   DISULFID        376..387
FT                   /evidence="ECO:0000250"
FT   DISULFID        381..398
FT                   /evidence="ECO:0000250"
FT   DISULFID        400..409
FT                   /evidence="ECO:0000250"
FT   DISULFID        416..429
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        423..438
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        440..449
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        456..467
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        461..476
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        478..487
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        494..505
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        499..514
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        516..525
FT                   /evidence="ECO:0000269|PubMed:25700513,
FT                   ECO:0007744|PDB:4XL1"
FT   DISULFID        532..543
FT                   /evidence="ECO:0000250"
FT   DISULFID        537..552
FT                   /evidence="ECO:0000250"
FT   DISULFID        554..563
FT                   /evidence="ECO:0000250"
FT   DISULFID        570..580
FT                   /evidence="ECO:0000250"
FT   DISULFID        575..589
FT                   /evidence="ECO:0000250"
FT   DISULFID        591..600
FT                   /evidence="ECO:0000250"
FT   DISULFID        607..618
FT                   /evidence="ECO:0000250"
FT   DISULFID        612..627
FT                   /evidence="ECO:0000250"
FT   DISULFID        629..638
FT                   /evidence="ECO:0000250"
FT   DISULFID        645..655
FT                   /evidence="ECO:0000250"
FT   DISULFID        650..664
FT                   /evidence="ECO:0000250"
FT   DISULFID        666..675
FT                   /evidence="ECO:0000250"
FT   DISULFID        682..693
FT                   /evidence="ECO:0000250"
FT   DISULFID        687..702
FT                   /evidence="ECO:0000250"
FT   DISULFID        704..713
FT                   /evidence="ECO:0000250"
FT   DISULFID        720..730
FT                   /evidence="ECO:0000250"
FT   DISULFID        725..739
FT                   /evidence="ECO:0000250"
FT   DISULFID        741..750
FT                   /evidence="ECO:0000250"
FT   DISULFID        757..768
FT                   /evidence="ECO:0000250"
FT   DISULFID        762..777
FT                   /evidence="ECO:0000250"
FT   DISULFID        779..788
FT                   /evidence="ECO:0000250"
FT   DISULFID        795..806
FT                   /evidence="ECO:0000250"
FT   DISULFID        800..815
FT                   /evidence="ECO:0000250"
FT   DISULFID        817..826
FT                   /evidence="ECO:0000250"
FT   DISULFID        833..844
FT                   /evidence="ECO:0000250"
FT   DISULFID        838..855
FT                   /evidence="ECO:0000250"
FT   DISULFID        857..866
FT                   /evidence="ECO:0000250"
FT   DISULFID        873..884
FT                   /evidence="ECO:0000250"
FT   DISULFID        878..893
FT                   /evidence="ECO:0000250"
FT   DISULFID        895..904
FT                   /evidence="ECO:0000250"
FT   DISULFID        911..922
FT                   /evidence="ECO:0000250"
FT   DISULFID        916..931
FT                   /evidence="ECO:0000250"
FT   DISULFID        933..942
FT                   /evidence="ECO:0000250"
FT   DISULFID        949..960
FT                   /evidence="ECO:0000250"
FT   DISULFID        954..969
FT                   /evidence="ECO:0000250"
FT   DISULFID        971..980
FT                   /evidence="ECO:0000250"
FT   DISULFID        987..998
FT                   /evidence="ECO:0000250"
FT   DISULFID        992..1007
FT                   /evidence="ECO:0000250"
FT   DISULFID        1009..1018
FT                   /evidence="ECO:0000250"
FT   DISULFID        1025..1036
FT                   /evidence="ECO:0000250"
FT   DISULFID        1030..1045
FT                   /evidence="ECO:0000250"
FT   DISULFID        1047..1056
FT                   /evidence="ECO:0000250"
FT   DISULFID        1063..1074
FT                   /evidence="ECO:0000250"
FT   DISULFID        1068..1083
FT                   /evidence="ECO:0000250"
FT   DISULFID        1085..1094
FT                   /evidence="ECO:0000250"
FT   DISULFID        1101..1122
FT                   /evidence="ECO:0000305"
FT   DISULFID        1116..1131
FT                   /evidence="ECO:0000250"
FT   DISULFID        1133..1142
FT                   /evidence="ECO:0000250"
FT   DISULFID        1149..1160
FT                   /evidence="ECO:0000250"
FT   DISULFID        1154..1169
FT                   /evidence="ECO:0000250"
FT   DISULFID        1171..1180
FT                   /evidence="ECO:0000250"
FT   DISULFID        1187..1198
FT                   /evidence="ECO:0000250"
FT   DISULFID        1192..1207
FT                   /evidence="ECO:0000250"
FT   DISULFID        1209..1218
FT                   /evidence="ECO:0000250"
FT   DISULFID        1225..1244
FT                   /evidence="ECO:0000250"
FT   DISULFID        1238..1253
FT                   /evidence="ECO:0000250"
FT   DISULFID        1255..1264
FT                   /evidence="ECO:0000250"
FT   DISULFID        1271..1284
FT                   /evidence="ECO:0000250"
FT   DISULFID        1276..1293
FT                   /evidence="ECO:0000250"
FT   DISULFID        1295..1304
FT                   /evidence="ECO:0000250"
FT   DISULFID        1311..1322
FT                   /evidence="ECO:0000250"
FT   DISULFID        1316..1334
FT                   /evidence="ECO:0000250"
FT   DISULFID        1336..1345
FT                   /evidence="ECO:0000250"
FT   DISULFID        1352..1363
FT                   /evidence="ECO:0000250"
FT   DISULFID        1357..1372
FT                   /evidence="ECO:0000250"
FT   DISULFID        1374..1383
FT                   /evidence="ECO:0000250"
FT   DISULFID        1391..1403
FT                   /evidence="ECO:0000250"
FT   DISULFID        1397..1414
FT                   /evidence="ECO:0000250"
FT   DISULFID        1416..1425
FT                   /evidence="ECO:0000250"
FT   DISULFID        1449..1472
FT                   /evidence="ECO:0000250"
FT   DISULFID        1454..1467
FT                   /evidence="ECO:0000250"
FT   DISULFID        1463..1479
FT                   /evidence="ECO:0000250"
FT   DISULFID        1490..1514
FT                   /evidence="ECO:0000250"
FT   DISULFID        1496..1509
FT                   /evidence="ECO:0000250"
FT   DISULFID        1505..1521
FT                   /evidence="ECO:0000250"
FT   DISULFID        1536..1549
FT                   /evidence="ECO:0000250"
FT   DISULFID        1545..1561
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        1749
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q01705"
FT   CONFLICT        309
FT                   /note="G -> A (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="E -> D (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="S -> R (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        577
FT                   /note="Y -> I (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        951
FT                   /note="S -> T (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1339
FT                   /note="G -> R (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1435
FT                   /note="G -> A (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1595..1596
FT                   /note="EL -> DV (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2501
FT                   /note="P -> R (in Ref. 1; CAA40667)"
FT                   /evidence="ECO:0000305"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          327..331
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          349..353
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          356..360
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          366..370
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   HELIX           375..378
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          386..389
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   TURN            391..393
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          396..399
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   STRAND          404..406
FT                   /evidence="ECO:0007829|PDB:5UK5"
FT   HELIX           415..418
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   TURN            424..426
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          428..432
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          435..439
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          444..446
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   TURN            455..458
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          466..470
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          473..477
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          482..484
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   TURN            493..496
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          504..507
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   STRAND          512..515
FT                   /evidence="ECO:0007829|PDB:4XL1"
FT   TURN            522..525
FT                   /evidence="ECO:0007829|PDB:4XL1"
SQ   SEQUENCE   2531 AA;  270822 MW;  3E61AE863AA237F2 CRC64;
     MPRLLAPLLC LTLLPALAAR GLRCSQPSGT CLNGGRCEVA NGTEACVCSG AFVGQRCQDP
     SPCLSTPCKN AGTCYVVDHG GIVDYACSCP LGFSGPLCLT PLANACLANP CRNGGTCDLL
     TLTEYKCRCP PGWSGKSCQQ ADPCASNPCA NGGQCLPFES SYICGCPPGF HGPTCRQDVN
     ECSQNPGLCR HGGTCHNEIG SYRCACRATH TGPHCELPYV PCSPSPCQNG GTCRPTGDTT
     HECACLPGFA GQNCEENVDD CPGNNCKNGG ACVDGVNTYN CRCPPEWTGQ YCTEDVDECQ
     LMPNACQNGG TCHNSHGGYN CVCVNGWTGE DCSENIDDCA SAACFQGATC HDRVASFYCE
     CPHGRTGLLC HLNDACISNP CNEGSNCDTN PVNGKAICTC PSGYTGPACS QDVDECALGA
     NPCEHAGKCL NTLGSFECQC LQGYTGPRCE IDVNECISNP CQNDATCLDQ IGEFQCICMP
     GYEGVYCEIN TDECASSPCL HNGRCVDKIN EFLCQCPKGF SGHLCQYDVD ECASTPCKNG
     AKCLDGPNTY TCVCTEGYTG THCEVDIDEC DPDPCHYGLC KDGVATFTCL CQPGYTGHHC
     ETNINECHSQ PCRHGGTCQD RDNYYLCLCL KGTTGPNCEI NLDDCASNPC DSGTCLDKID
     GYECACEPGY TGSMCNVNID ECAGSPCHNG GTCEDGIAGF TCRCPEGYHD PTCLSEVNEC
     NSNPCIHGAC RDGLNGYKCD CAPGWSGTNC DINNNECESN PCVNGGTCKD MTSGYVCTCR
     EGFSGPNCQT NINECASNPC LNQGTCIDDV AGYKCNCPLP YTGATCEVVL APCATSPCKN
     SGVCKESEDY ESFSCVCPTG WQGQTCEIDI NECVKSPCRH GASCQNTNGS YRCLCQAGYT
     GRNCESDIDD CRPNPCHNGG SCTDGVNAAF CDCLPGFQGA FCEEDINECA SNPCQNGANC
     TDCVDSYTCT CPTGFNGIHC ENNTPDCTES SCFNGGTCVD GINSFTCLCP PGFTGSYCQY
     DVNECDSRPC LHGGTCQDSY GTYKCTCPQG YTGLNCQNLV RWCDSAPCKN GGKCWQTNTQ
     YHCECRSGWT GFNCDVLSVS CEVAAQKRGI DVTLLCQHGG LCVDEEDKHY CHCQAGYTGS
     YCEDEVDECS PNPCQNGATC TDYLGGFSCK CVAGYHGSNC SEEINECLSQ PCQNGGTCID
     LTNTYKCSCP RGTQGVHCEI NVDDCHPPLD PASRSPKCFN NGTCVDQVGG YTCTCPPGFV
     GERCEGDVNE CLSNPCDPRG TQNCVQRVND FHCECRAGHT GRRCESVING CRGKPCRNGG
     VCAVASNTAR GFICRCPAGF EGATCENDAR TCGSLRCLNG GTCISGPRSP TCLCLGSFTG
     PECQFPASSP CVGSNPCYNQ GTCEPTSESP FYRCLCPAKF NGLLCHILDY SFTGGAGRDI
     PPPQIEEACE LPECQEDAGN KVCNLQCNNH ACGWDGGDCS LNFNDPWKNC TQSLQCWKYF
     SDGHCDSQCN SAGCLFDGFD CQLTEGQCNP LYDQYCKDHF SDGHCDQGCN SAECEWDGLD
     CAEHVPERLA AGTLVLVVLL PPDQLRNNSF HFLRELSHVL HTNVVFKRDA QGQQMIFPYY
     GREEELRKHP IKRSAVGWAT TSLLPGTNGG RQRRELDPMD IHGSIVYLEI DNRQCVQSSS
     QCFQSATDVA AFLGALASLG SLNIPYKIEA VKSETVEPPL PSQLHLMYVA AAAFVLLFFV
     GCGVLLSRKR RRQHGQLWFP EGFKVSEASK KKRREPLGED SVGLKPLKNA SDGALMDDNQ
     NEWGDEDLET KKFRFEEPVV LPDLDDQTDH RQWTQQHLDA ADLRVSAMAP TPPQGEVDAD
     CMDVNVRGPD GFTPLMIASC SGGGLETGNS EEEEDAPAVI SDFIYQGASL HNQTDRTGET
     ALHLAARYSR SDAAKRLLEA SADANIQDNM GRTPLHAAVS ADAQGVFQIL LRNRATDLDA
     RMHDGTTPLI LAARLAVEGM LEDLINSHAD VNAVDDLGKS ALHWAAAVNN VDAAVVLLKN
     GANKDMQNNK EETPLFLAAR EGSYETAKVL LDHFANRDIT DHMDRLPRDI AQERMHHDIV
     RLLDEYNLVR SPQLHGTALG GTPTLSPTLC SPNGYLGNLK SATQGKKARK PSTKGLACSS
     KEAKDLKARR KKSQDGKGCL LDSSSMLSPV DSLESPHGYL SDVASPPLLP SPFQQSPSMP
     LSHLPGMPDT HLGISHLNVA AKPEMAALAG GSRLAFEPPP PRLSHLPVAS SASTVLSTNG
     TGAMNFTVGA PASLNGQCEW LPRLQNGMVP SQYNPLRPGV TPGTLSTQAA GLQHGMMGPI
     HSSLSTNTLS PIIYQGLPNT RLATQPHLVQ TQQVQPQNLQ IQPQNLQPPS QPHLSVSSAA
     NGHLGRSFLS GEPSQADVQP LGPSSLPVHT ILPQESQALP TSLPSSMVPP MTTTQFLTPP
     SQHSYSSSPV DNTPSHQLQV PEHPFLTPSP ESPDQWSSSS PHSNISDWSE GISSPPTSMP
     SQITHIPEAF K
//
